Total RNA was extracted
via RiboEx reagent (GeneAll, Korea) according to the manufacturer’s protocol. The total RNA of clinical tissue was extracted
via grinding them in 1
ml RiboEx reagent using porcelain glass grinder. Complete DNA (cDNA) was synthesized from 1
μg of total RNA using
cDNA synthesis kit (Biofact, Korea). Then, qRT-PCR technique was applied to assess gene expressions. First, total RNA of tumor tissues and cells were extracted using the
RiboEx reagent (GeneAll, Korea) according to the manufacturer’s protocol. Then, total RNA was quantified and qualified by
NanoDrop Spectrophotometer (Thermo Fisher Scientific, USA) and agarose gel electrophoresis, respectively. Thereafter, cDNA was synthesized by a
cDNA synthesis kit (Takara, Japan). Finally, mRNA expressions were examined by the
Roche LightCycler system (Roche, Germany) by applying
SYBR Premix Ex Taq (Takara, Japan). Relative Nrf2, PD-L1, and CD80 mRNA expressions in tissue samples were analyzed through the 2
–ΔΔCt method, in which endogenous β actin was considered as an internal control. However, for the assessment of raw data from the cell samples, Pffafl method was applied and
GAPDH gene was considered as an internal control. All of the experiments were performed at least in triplicate.
Payandeh Z., Pirpour Tazehkand A., Mansoori B., Khaze V., Asadi M., Baradaran B, & Samadi N. (2021). The Impact of Nrf2 Silencing on Nrf2-PD-L1 Axis to Overcome Oxaliplatin Resistance and Migration in Colon Cancer Cells. Avicenna Journal of Medical Biotechnology, 13(3), 116-122.